{
    "clinical_study": {
        "@rank": "14982", 
        "arm_group": [
            {
                "arm_group_label": "Continuous positive airway pressure (CPAP) device.", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard CPAP therapy"
            }, 
            {
                "arm_group_label": "Auto-CPAP device (SPAP).", 
                "arm_group_type": "Experimental", 
                "description": "Novel Auto-CPAP algorithm"
            }
        ], 
        "brief_summary": {
            "textblock": "This single-blind randomised crossover trial aims to compare the efficacy of a novel\n      Auto-CPAP algorithm (SPAP) to conventional CPAP. Up to 50 patients will be recruited from an\n      OSA population, aged over 18."
        }, 
        "brief_title": "Novel Auto-continuous Positive Airway Pressure (CPAP) Validation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea, Obstructive", 
        "condition_browse": {
            "mesh_term": [
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Auto-CPAP devices change therapeutic pressure based on the needs of the patient. Algorithms\n      differ from machine to machine. This single-blind randomised crossover trial aims to compare\n      the efficacy of SPAP (a novel Auto-CPAP algorithm) to conventional CPAP.\n\n      Up to 50 patients will be recruited from an OSA population, aged over 18. Participants will\n      consist of male and female patients diagnosed with moderate\u2212severe OSA (Apnea Hypopnea Index\n      (AHI) greater than or equal to 15 per hour. Eligible participants, according to the protocol\n      approved by the Northern X Region Ethics Committee, providing written informed consent will\n      be enrolled into the study. Patients will be enrolled sequentially according to the\n      randomisation list. Patients will be randomised to CPAP or SPAP.\n\n      The therapeutic pressure will be based on the most recent titration night of each patient.\n      Comparisons between data will be made using a one-tailed t-test for non-inferiority of the\n      SPAP algorithm compared with conventional CPAP therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged \u226518 years with mild-to-severe OSA (Apnea Hypopnea Index equal to or greater than\n             5 per hour).\n\n        Exclusion Criteria:\n\n          -  Any medical condition which contraindicates (see Appendix A) the use of CPAP or\n             AutoCPAP.\n\n          -  Unstable cardiovascular disease (untreated or resistant hypertension acceptable).\n\n          -  Unstable psychiatric disease.\n\n          -  Other significant sleep disorder.\n\n          -  Inability to tolerate CPAP due to nasal obstruction or claustrophobia, as determined\n             by the investigation investigator.\n\n          -  Any known factor or disease that might interfere with treatment compliance,\n             investigation conduct or interpretation of the results such as psychiatric disease,\n             history of non compliance to medical regimens, or unwillingness to comply with\n             investigational requirements.\n\n          -  Participation in another clinical trial in the previous month.\n\n          -  Less than 2 hours recorded sleep in either arm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 10, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943708", 
            "org_study_id": "FPH-SA-10-07"
        }, 
        "intervention": [
            {
                "arm_group_label": "Auto-CPAP device (SPAP).", 
                "description": "Novel Auto-algorithm for Auto-CPAP device", 
                "intervention_name": "SPAP", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Continuous positive airway pressure (CPAP) device.", 
                "description": "Standard CPAP therapy", 
                "intervention_name": "CPAP", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 16, 2013", 
        "location": {
            "contact": {
                "email": "Rachel.Vicars@fphcare.co.nz", 
                "last_name": "Rachel Vicars, PhD", 
                "phone": "+64 9 574 0123", 
                "phone_ext": "7759"
            }, 
            "facility": {
                "address": {
                    "city": "Auckland", 
                    "country": "New Zealand"
                }, 
                "name": "Fisher and Paykel Healthcare Sleep Lab"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "New Zealand"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Study to Validate a Novel Auto Continuous Positive Airway Pressure Therapy", 
        "overall_contact": {
            "email": "Rachel.Vicars@fphcare.co.nz", 
            "last_name": "Rachel Vicars, PhD", 
            "phone": "+64 9 574 0123", 
            "phone_ext": "7759"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "New Zealand: Health and Disability Ethics Committees", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The apnea hypopnea index (AHI) is a measure of sleep disordered breathing. It will be measured and compared between the two groups. The units are number of events per hour.", 
            "measure": "AHI", 
            "safety_issue": "No", 
            "time_frame": "one post study night (once PSG is scored)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943708"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Fisher and Paykel Healthcare", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fisher and Paykel Healthcare", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2011"
    }
}